Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-15-011245
Filing Date
2015-03-11
Accepted
2015-03-10 19:44:08
Documents
16
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-K 12-31-2014 form10k.htm 10-K 1579408
2 EXHIBIT 10.25 ex10_25.htm EX-10.25 64111
3 EXHIBIT 10.26 ex10_26.htm EX-10.26 237737
4 EXHIBIT 10.27 ex10_27.htm EX-10.27 154339
5 EXHIBIT 23.1 ex23_1.htm EX-23.1 2674
6 EXHIBIT 23.2 ex23_2.htm EX-23.2 3187
7 EXHIBIT 31 ex31.htm EX-31 14122
8 EXHIBIT 32 ex32.htm EX-32 5448
15 image00004.jpg GRAPHIC 50874
16 image00005.jpg GRAPHIC 31126
  Complete submission text file 0001140361-15-011245.txt   8965100

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ast-20141231.xml EX-101.INS 910211
10 XBRL TAXONOMY EXTENSION SCHEMA ast-20141231.xsd EX-101.SCH 61093
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20141231_cal.xml EX-101.CAL 63729
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20141231_def.xml EX-101.DEF 248868
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20141231_lab.xml EX-101.LAB 810993
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20141231_pre.xml EX-101.PRE 452612
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36646 | Film No.: 15690701
SIC: 2836 Biological Products, (No Diagnostic Substances)